Bicocca Open Archive

Logo unimib boa
FRUSCIO, ROBERT
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 27.516
AS - Asia 19.279
EU - Europa 13.781
SA - Sud America 2.695
AF - Africa 454
OC - Oceania 69
Continente sconosciuto - Info sul continente non disponibili 26
Totale 63.820
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.005
SG - Singapore 6.445
IT - Italia 4.103
CN - Cina 3.851
VN - Vietnam 2.883
HK - Hong Kong 2.505
RU - Federazione Russa 2.027
BR - Brasile 1.941
DE - Germania 1.328
CA - Canada 1.192
IE - Irlanda 1.177
SE - Svezia 1.058
BD - Bangladesh 867
FR - Francia 768
GB - Regno Unito 754
UA - Ucraina 711
IN - India 533
FI - Finlandia 387
ID - Indonesia 366
KR - Corea 306
TR - Turchia 294
ES - Italia 282
AR - Argentina 246
NL - Olanda 245
JP - Giappone 211
AT - Austria 210
IQ - Iraq 194
MX - Messico 192
ZA - Sudafrica 138
CO - Colombia 134
SA - Arabia Saudita 118
PL - Polonia 112
PH - Filippine 104
PK - Pakistan 103
EC - Ecuador 96
DK - Danimarca 92
CH - Svizzera 84
VE - Venezuela 77
BE - Belgio 71
CL - Cile 69
CZ - Repubblica Ceca 66
MA - Marocco 63
EG - Egitto 59
AU - Australia 58
UZ - Uzbekistan 52
PE - Perù 50
TH - Thailandia 50
MY - Malesia 46
AE - Emirati Arabi Uniti 45
GR - Grecia 45
RO - Romania 43
KE - Kenya 41
PT - Portogallo 40
PY - Paraguay 39
TN - Tunisia 36
IR - Iran 33
JM - Giamaica 31
SK - Slovacchia (Repubblica Slovacca) 30
JO - Giordania 27
UY - Uruguay 27
IL - Israele 25
LT - Lituania 25
NP - Nepal 24
ET - Etiopia 22
BG - Bulgaria 21
CR - Costa Rica 21
DZ - Algeria 20
KZ - Kazakistan 20
PS - Palestinian Territory 20
LB - Libano 18
AZ - Azerbaigian 17
RS - Serbia 17
TW - Taiwan 17
AL - Albania 16
HN - Honduras 16
OM - Oman 16
EU - Europa 15
LV - Lettonia 15
SN - Senegal 15
GT - Guatemala 11
HU - Ungheria 11
KH - Cambogia 10
KW - Kuwait 10
LK - Sri Lanka 10
BO - Bolivia 9
CI - Costa d'Avorio 9
MD - Moldavia 9
NG - Nigeria 9
NI - Nicaragua 9
A2 - ???statistics.table.value.countryCode.A2??? 8
BA - Bosnia-Erzegovina 8
DO - Repubblica Dominicana 8
KG - Kirghizistan 8
SV - El Salvador 8
AO - Angola 7
BH - Bahrain 7
GE - Georgia 7
NZ - Nuova Zelanda 7
BY - Bielorussia 6
GY - Guiana 6
Totale 63.697
Salva come PNG Salva come JPEG
Città #
Singapore 3.665
Ann Arbor 3.294
Ashburn 2.628
Hong Kong 2.442
Woodbridge 1.571
San Jose 1.532
Fairfield 1.493
Dublin 1.119
Houston 1.109
Milan 1.000
Chandler 948
Ho Chi Minh City 871
Wilmington 827
Toronto 813
New York 763
Hanoi 699
Jacksonville 697
Frankfurt am Main 675
Seattle 654
Santa Clara 608
Hefei 604
Los Angeles 560
Cambridge 520
Dallas 513
Chicago 506
Dearborn 489
The Dalles 441
Beijing 426
Princeton 426
Rome 321
Boardman 286
Seoul 279
Lauterbourg 272
Jakarta 266
Council Bluffs 246
Hangzhou 225
Moscow 219
Buffalo 213
Nanjing 212
Shanghai 196
Lawrence 193
Altamura 170
São Paulo 170
Helsinki 164
Vienna 145
Tokyo 128
Lachine 112
Nuremberg 112
San Diego 111
London 109
Da Nang 108
Guangzhou 105
Orem 91
Munich 90
Haiphong 89
Lissone 87
Nanchang 79
Baghdad 77
Atlanta 75
Columbus 75
Chennai 74
Montreal 74
Brooklyn 71
Johannesburg 68
Istanbul 67
Naples 67
Ottawa 67
Denver 64
Warsaw 64
Rio de Janeiro 63
Andover 62
Lappeenranta 61
Turin 60
Amsterdam 58
Shenyang 57
Dong Ket 56
Changsha 52
Fremont 52
Bologna 51
Brno 50
Florence 50
Salt Lake City 49
Kent 48
Phoenix 48
Washington 48
Biên Hòa 47
Manchester 46
San Francisco 46
Dhaka 45
Hải Dương 45
Jinan 45
Ankara 44
Hebei 44
Tashkent 44
Zurich 44
Mexico City 43
Brussels 42
Mumbai 42
Poplar 42
Belo Horizonte 41
Totale 39.059
Salva come PNG Salva come JPEG
Nome #
Association between multimorbidity and postoperative mortality in patients undergoing major surgery: a prospective study in 29 countries across Europe 1.082
Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group 986
Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries 597
Oncologic and fertility impact of surgical approach for borderline ovarian tumours treated with fertility sparing surgery 542
Management and outcome of colorectal cancer during pregnancy: report of 41 cases 538
Radiomics of the primary tumour as a tool to improve 18F-FDG-PET sensitivity in detecting nodal metastases in endometrial cancer 476
Multisite analysis of high-grade serous epithelial ovarian cancers identifies genomic regions of focal and recurrent copy number alteration in 3q26.2 and 8q24.3 475
Bilateral Oophorectomy and All-Cause Mortality in Women With BRCA1 and BRCA2 Sequence Variations 460
Role of 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in malignant ovarian germ cell tumors: a single-center experience with long term follow-up 452
Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients 449
Ovarian function, fertility, and menopause occurrence after fertility-sparing surgery and chemotherapy for ovarian neoplasms 436
Prevalence of human papillomavirus (HPV) and other sexually transmitted infections (STIS) among italian women referred for a colposcopy 398
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score 398
Staging of High-Risk Endometrial Cancer With PET/CT and Sentinel Lymph Node Mapping 397
Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study 374
Detection of TP53 Clonal Variants in Papanicolaou Test Samples Collected up to 6 Years Prior to High-Grade Serous Epithelial Ovarian Cancer Diagnosis 372
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak 368
Early-stage clear cell ovarian cancer compared to high-grade histological subtypes: An outcome exploratory analysis in two oncology centers 363
18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer 362
Histologic and metabolic assessment in a cohort of patients with genital prolapse: Preoperative stage and recurrence investigations 362
Iliococcygeus fixation or abdominal sacral colpopexy for the treatment of vaginal vault prolapse: a retrospective cohort study 350
Long-term results of fertility-sparing treatment compared with standard radical surgery for early-stage epithelial ovarian cancer 346
Two ultrastaging protocols for the detection of lymph node metastases in early-stage cervical and endometrial cancers 346
Randomized phase III clinical trial evaluating weekly cisplatin for advanced epithelial ovarian cancer 344
Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT 342
Preoperative staging of cervical cancer: is 18-FDG-PET/CT really effective in patients with early stage disease? 335
Clinical and ultrasound characteristics of the microcystic elongated and fragmented (MELF) pattern in endometrial cancer according to the International Endometrial Tumor Analysis (IETA) criteria 331
Characteristics of patients with cervical cancer during pregnancy: A multicenter matched cohort study. An initiative from the International Network on Cancer, Infertility and Pregnancy 330
Preoperative 18F-FDG PET/CT in the management of advanced epithelial ovarian cancer 322
LncRNAs as novel indicators of patients' prognosis in stage i epithelial ovarian cancer: A retrospective and multicentric study 320
Better anatomical and cosmetic results using tunneled lotus petal flap for plastic reconstruction after demolitive surgery for vulvar malignancyc 318
The paradigm shift in advanced ovarian cancer: Outcomes of extensive primary cytoreductive surgery. A single-center retrospective analysis 316
A prognostic regulatory pathway in stage I epithelial ovarian cancer: New hints for the poor prognosis assessment 315
OC13. 02: Reproducibility of IETA terms in describing endometrial pathology 314
Genome-wide Copy-number Alterations in Circulating Tumor DNA as a Novel Biomarker for Patients with High-grade Serous Ovarian Cancer 312
The contribution of a collagen-fibrin patch (Tachosil) to prevent the postoperative lymphatic complications after groin lymphadenectomy: A double institution observational study 311
Treatment of simple and complex endometrial non-atypical hyperplasia with natural progesterone: response rate to different doses 306
Impact of postoperative cardiovascular complications on 30-day mortality after major abdominal surgery: an international prospective cohort study 300
Detection of nodal metastases by 18F-FDG PET/CT in apparent early stage ovarian cancer: a prospective study 297
Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2-year interim analysis of a multicentre, prospective, cohort study 297
Conservative management of early-stage epithelial ovarian cancer: results of a large retrospective series 296
Ovarian carcinoma tumor-initiating cells have a mesenchymal phenotype 296
Tubal histopathological abnormalities in BRCA1/2 mutation carriers undergoing prophylactic salpingo-oophorectomy: a case-control study 296
Is there any therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer? 294
Child development at 6 years after maternal cancer diagnosis and treatment during pregnancy 293
Delaying surgery for patients with a previous SARS-CoV-2 infection 289
Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries 285
Ovarian Carcinoma Xenografts–Drug Response and Molecular Characterization 282
GestaTIonal TrophoblAstic NeoplasIa Ultrasound assessMent: TITANIUM study 276
Real-Time Single-Walled Carbon Nanotube-Based Fluorescence Imaging Improves Survival after Debulking Surgery in an Ovarian Cancer Model 275
The role of pelvic and aortic lymphadenectomy at second look surgery in apparent early stage ovarian cancer after inadequate surgical staging followed by adjuvant chemotherapy 272
Diagnosis and management of isolated serous tubal intraepithelial carcinoma: A qualitative focus group study 271
925pmatched cohort study on patients with cervical cancer diagnosed during pregnancy 271
Synchronous early-stage endometrial and ovarian cancer 270
Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group 269
Gynecologic cancers in pregnancy: Guidelines based on a third international consensus meeting 269
601: Cisplatin response in a panel of patient-derived ovarian carcinoma xenografts: roles of epithelial mesenchymal transition and DNA repair 265
Ultrasound characteristics of endometrial cancer as defined by the International Endometrial Tumor Analysis (IETA) consensus nomenclature - A prospective multicenter study 265
Systematic lymphadenectomy in ovarian cancer at second-look surgery: a randomised clinical trial 263
Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: a retrospective study 261
Maximum standardized uptake value (SUVmax) as prognostic factor for surgical cytoreduction and response to adjuvant chemotherapy in women submitted to 18F-FDG PET/CT for staging of advanced epithelial ovarian cancer (aEOC) 261
Regional and temporal heterogeneity of epithelial ovarian cancer tumor biopsies: implications for therapeutic strategies 257
Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer 256
Evaluation of Human Papilloma Virus (HPV) Genotyping and Viral Load Determination as Diagnostic Biomarkers of Cervical Cancer Risk 255
Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer 255
Ascites interferes with the activity of lurbinectedin and trabectedin: Potential role of their binding to alpha 1-acid glycoprotein 254
Outcome of patients with stage I immature teratoma after surveillance or adjuvant chemotherapy 253
Adjuvant sequential chemo and radiotherapy improves the oncological outcome in high risk endometrial cancer 253
Accuracy of Human Papillomavirus (HPV) Testing on Urine and Vaginal Self-Samples Compared to Clinician-Collected Cervical Sample in Women Referred to Colposcopy 251
Efficacy of a Diode Vaginal Laser in the Treatment of the Genitourinary Syndrome of Menopause 251
Delivery delay with neoadjuvant chemotherapy for cervical cancer patients during pregnancy: A series of nine cases and literature review 251
The use of TachoSil for the prevention of postoperative complications after groin dissection in cases of gynecologic malignancy 250
Association between physical activity and menstrual cycle disorders in young athletes 249
Clinical utility of risk modelsto refer patients with adnexal masses to specialized oncology care: Multicenter external validation using decision curve analysis 249
A phase II clinical trial of topotecan and carboplatin in patients with newly diagnosed advanced epithelial ovarian cancer 245
Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections 245
Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study 243
Borderline ovarian cancer 243
Molecular Detection of Human Papillomavirus (HPV) and Other Sexually Transmitted Pathogens in Cervical and Self-Collected Specimens 242
Fertility outcomes in stage I ovarian immature teratomas 241
Long-term follow-up of patients with an isolated ovarian recurrence after conservative treatment of epithelial ovarian cancer: review of the results of an international multicenter study comprising 545 patients 240
PRL-3 phosphatase is implicated in ovarian cancer growth 239
Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients 238
Platinum sensitivity and DNA repair in a recently established panel of patient-derived ovarian carcinoma xenografts 237
Patient-derived ovarian tumor xenografts recapitulate human clinicopathology and genetic alterations 236
Managing Ovarian tumors during pregnancy 236
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer 236
Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers 235
Evaluation of two alternative non-alcohol-based media for the suspension of self-collected vaginal swabs for HPV testing in cervical cancer screening 233
DNA-damage response gene polymorphisms and therapeutic outcomes in ovarian cancer 233
An exploration of body image distress in women who underwent a prophylactic bilateral salpingo-oophorectomy (PBSO) 233
A phase II randomised clinical trial comparing cisplatin, paclitaxel and ifosfamide with cisplatin, paclitaxel and epirubicin in newly diagnosed advanced epithelial ovarian cancer: long-term survival analysis 230
Assessment of nodal status by 18F-FDG PET/CT in early stage ovarian cancer 230
Imaging in gynecological disease (14): clinical and ultrasound characteristics of ovarian clear cell carcinoma 230
Copy number alterations in stage I epithelial ovarian cancer highlight three genomic patterns associated with prognosis 227
A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts 226
Expression of DNA repair genes in ovarian cancer samples: biological and clinical considerations 226
Ultrasound characteristics of endometrial hyperplasia described using IETA terms 226
Evaluation of BD Onclarity™ HPV Assay on Self-Collected Vaginal and First-Void Urine Samples as Compared to Clinician-Collected Cervical Samples: A Pilot Study 225
Management of primary and recurrent Bartholin’s gland carcinoma: A systematic review on behalf of MITO Rare Cancer Group 224
Totale 31.541
Salva come PNG Salva come JPEG
Categoria #
all - tutte 213.514
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 213.514
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021352 0 0 0 0 0 0 0 0 0 0 0 352
2021/20222.629 205 226 211 250 149 252 121 147 139 254 218 457
2022/20234.327 475 1.202 357 329 253 688 118 247 326 44 162 126
2023/20244.313 127 142 238 269 503 948 776 184 352 133 123 518
2024/202511.485 583 1.228 523 532 901 610 604 537 1.227 1.683 1.027 2.030
2025/202627.862 3.093 2.037 1.923 2.581 2.816 1.364 3.485 1.323 2.085 2.479 2.218 2.458
Totale 65.195